\begin{table}[htbp]
\centering
\caption{ATT(g,t) Matrix: Decomposing the Aggregate CS-DiD Estimate}
\label{tab:att_gt}
\footnotesize
\begin{tabular}{lccccccc}
\toprule
 & \multicolumn{7}{c}{Year $t$} \\
\cmidrule(lr){2-8}
Cohort $g$ & 2017 & 2018 & 2019 & 2021 & 2022 & 2023 & 2024 \\
\midrule
2021 & --- & -0.008 & -0.003 & -0.006 & -0.017 & -0.006 & --- \\
2022 & --- & -0.010 & -0.003 & -0.026 & -0.004 & -0.006 & --- \\
2023 & --- & 0.006 & -0.017 & -0.024 & 0.019 & 0.004 & --- \\
\midrule
Overall ATT (simple) & \multicolumn{7}{c}{-0.0050 (SE = 0.0063)} \\
\bottomrule
\end{tabular}
\begin{tablenotes}[flushleft]
\small
\item \textit{Notes:} Each cell reports $ATT(g,t)$ from Callaway \& Sant'Anna (2021).
Pre-treatment cells ($t < g$) should be near zero under parallel trends.
Post-treatment cells ($t \geq g$) contribute to the aggregate ATT weighted by group size.
* indicates $|ATT/SE| > 1.96$. --- indicates cell not estimated.
The overall ATT is the group-size-weighted average of post-treatment cells.
\end{tablenotes}
\end{table}

